Castellan Group’s Bristol-Myers Squibb BMY Stock Holding History

Castellan Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,700	Closed	-$215K	–	59
2023 Q3	$215K	Sell	3,700 -300	-8%	-$18.4K	0.15%	58
2023 Q2	$256K	Sell	4,000 -26,725	-87%	-$1.79M	0.16%	59
2023 Q1	$2.13M	Sell	30,725 -165	-0.5%	-$11.6K	1.45%	42
2022 Q4	$2.22M	Buy	30,890 +16	+0.1%	+$1.21K	1.55%	41
2022 Q3	$2.19M	Buy	30,874 +1,430	+5%	+$104K	1.71%	27
2022 Q2	$2.27M	Sell	29,444 -1,345	-4%	-$102K	1.8%	24
2022 Q1	$2.25M	Buy	30,789 +3,389	+12%	+$228K	1.56%	31
2021 Q4	$1.71M	Buy	27,400 +3,350	+14%	+$197K	1.18%	39
2021 Q3	$1.42M	Sell	24,050 -3,150	-12%	-$207K	0.73%	59
2021 Q2	$1.82M	Buy	27,200 +2,400	+10%	+$156K	0.76%	35
2021 Q1	$1.57M	Buy	24,800 +1,500	+6%	+$93.3K	0.84%	37
2020 Q4	$1.45M	Buy	+23,300	New	+$1.43M	1.56%	15

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Castellan Group's BMY Position: Q4 2023 in Review

Castellan Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,700 shares — an estimated $215K sold.

Castellan Group first reported a position in BMY in Q4 2020 and held it in 12 quarters. The position peaked at $2.27M in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Castellan Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Castellan Group sold 3,700 Bristol-Myers Squibb shares in Q4 2023, an estimated $215K.
Castellan Group first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 12 quarters.
Castellan Group's Bristol-Myers Squibb position peaked at $2.27M in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Castellan Group's 13F filing for Q4 2023, filed 14 Feb 2024.